[go: up one dir, main page]

FR2661919B1 - Methode de preparation de derives de furo (3,4-c) pyridine sous forme non-racemique. - Google Patents

Methode de preparation de derives de furo (3,4-c) pyridine sous forme non-racemique.

Info

Publication number
FR2661919B1
FR2661919B1 FR9105766A FR9105766A FR2661919B1 FR 2661919 B1 FR2661919 B1 FR 2661919B1 FR 9105766 A FR9105766 A FR 9105766A FR 9105766 A FR9105766 A FR 9105766A FR 2661919 B1 FR2661919 B1 FR 2661919B1
Authority
FR
France
Prior art keywords
furo
preparation
pyridine derivatives
racemic form
racemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9105766A
Other languages
English (en)
Other versions
FR2661919A1 (fr
Inventor
Charles R Eck
C Ahrens
Marie Saltzstein Rae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of FR2661919A1 publication Critical patent/FR2661919A1/fr
Application granted granted Critical
Publication of FR2661919B1 publication Critical patent/FR2661919B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR9105766A 1990-05-14 1991-05-14 Methode de preparation de derives de furo (3,4-c) pyridine sous forme non-racemique. Expired - Lifetime FR2661919B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/523,238 US5130252A (en) 1990-05-14 1990-05-14 Resolution of furopyridine enantiomers and synthetic precursors thereof

Publications (2)

Publication Number Publication Date
FR2661919A1 FR2661919A1 (fr) 1991-11-15
FR2661919B1 true FR2661919B1 (fr) 1994-12-30

Family

ID=24084213

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9105766A Expired - Lifetime FR2661919B1 (fr) 1990-05-14 1991-05-14 Methode de preparation de derives de furo (3,4-c) pyridine sous forme non-racemique.

Country Status (32)

Country Link
US (1) US5130252A (fr)
JP (1) JPH05117277A (fr)
KR (1) KR910020015A (fr)
AR (1) AR247762A1 (fr)
AT (1) AT400445B (fr)
AU (1) AU642368B2 (fr)
BE (1) BE1007016A3 (fr)
CA (1) CA2042421C (fr)
CH (1) CH682488A5 (fr)
DE (1) DE4115681C2 (fr)
DK (1) DK88991A (fr)
DZ (1) DZ1499A1 (fr)
ES (1) ES2033574B1 (fr)
FI (1) FI97807C (fr)
FR (1) FR2661919B1 (fr)
GB (1) GB2244056B (fr)
GR (1) GR1001593B (fr)
HK (1) HK131993A (fr)
IE (1) IE65891B1 (fr)
IT (1) IT1248743B (fr)
LU (1) LU87935A1 (fr)
MA (1) MA22154A1 (fr)
MY (1) MY107567A (fr)
NL (1) NL194615C (fr)
NO (1) NO180308C (fr)
NZ (1) NZ238009A (fr)
OA (1) OA09352A (fr)
PT (1) PT97657B (fr)
SE (1) SE510808C2 (fr)
TN (1) TNSN91035A1 (fr)
TW (1) TW226998B (fr)
ZA (1) ZA913461B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
US20050043391A1 (en) * 2003-07-17 2005-02-24 Fong Benson M. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20110251396A1 (en) * 2003-07-17 2011-10-13 Gilead Sciences, Inc. Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
WO2005021039A1 (fr) * 2003-08-29 2005-03-10 Cotherix, Inc. Combinaison de cicletanine et antidiabetique a administration orale et/ou agent de reduction des lipides sanguins en vue du traitement du diabete et du syndrome metabolique
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
CA2593793A1 (fr) * 2005-01-05 2006-07-13 Medicure International Inc. Composes et techniques de regulation des niveaux de triglyceride
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
US20080312241A1 (en) * 2007-01-03 2008-12-18 Gilead Sciences, Inc. Cicletanine and PKC inhibitors in the treatment of pulmonary and cardiac disorders
WO2011053519A1 (fr) * 2009-10-29 2011-05-05 Merck Sharp & Dohme Corp. Diurétiques

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (fr) * 1981-02-10 1985-11-09 Scras
US4985365A (en) * 1981-11-28 1991-01-15 Sumitomo Chemical Company, Ltd. Process for producing optically active benzyl alcohol compound
EP0101076B1 (fr) * 1982-08-13 1989-01-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Procédé de préparation d'oxazolidinones optiquement actives
IN160104B (fr) * 1983-04-05 1987-06-27 Scras
JPS59216590A (ja) * 1983-05-24 1984-12-06 Ube Ind Ltd 光学活性フエニルプロパルギルアルコ−ル誘導体の製法
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
JPS60224494A (ja) * 1984-04-24 1985-11-08 Nissan Chem Ind Ltd α−メチルベンジルアルコ−ル類の光学分割法
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
JPS61289899A (ja) * 1985-06-18 1986-12-19 Kanegafuchi Chem Ind Co Ltd 光学活性２−ハロ−１−フエニルエタノ−ルおよびそのエステルの製造法
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3737335A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
NL8801311A (nl) * 1988-05-20 1989-12-18 Stamicarbon Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem.
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
GR1001593B (el) 1993-03-31
NZ238009A (en) 1992-11-25
AU7620091A (en) 1991-11-14
JPH05117277A (ja) 1993-05-14
DE4115681A1 (de) 1991-11-21
TNSN91035A1 (fr) 1992-10-25
GB2244056A (en) 1991-11-20
OA09352A (fr) 1992-09-15
NO911852D0 (no) 1991-05-13
ZA913461B (en) 1992-02-26
HK131993A (en) 1993-12-10
MA22154A1 (fr) 1991-12-31
SE9101431D0 (sv) 1991-05-13
US5130252A (en) 1992-07-14
AU642368B2 (en) 1993-10-14
IE65891B1 (en) 1995-11-29
CH682488A5 (fr) 1993-09-30
KR910020015A (ko) 1991-12-19
PT97657B (pt) 1998-09-30
PT97657A (pt) 1992-02-28
FI912315A0 (fi) 1991-05-13
ATA98291A (de) 1995-05-15
SE9101431L (sv) 1991-11-15
ES2033574A1 (es) 1993-03-16
IE911628A1 (en) 1991-11-20
GB9109810D0 (en) 1991-06-26
DE4115681C2 (de) 2003-10-30
TW226998B (fr) 1994-07-21
GR910100180A (en) 1992-07-30
FI97807B (fi) 1996-11-15
BE1007016A3 (fr) 1995-02-21
GB2244056B (en) 1993-08-11
ITMI911255A0 (it) 1991-05-08
NO180308B (no) 1996-12-16
FI97807C (fi) 1997-02-25
DK88991D0 (da) 1991-05-13
FR2661919A1 (fr) 1991-11-15
DK88991A (da) 1991-11-15
NO180308C (no) 1997-03-26
ITMI911255A1 (it) 1992-11-08
NL194615B (nl) 2002-05-01
LU87935A1 (fr) 1992-03-03
NL194615C (nl) 2002-09-03
AR247762A1 (es) 1995-03-31
AT400445B (de) 1995-12-27
MY107567A (en) 1996-04-30
CA2042421C (fr) 2000-08-22
NL9100749A (nl) 1991-12-02
SE510808C2 (sv) 1999-06-28
CA2042421A1 (fr) 1991-11-15
ES2033574B1 (es) 1994-02-01
DZ1499A1 (fr) 2004-09-13
FI912315L (fi) 1991-11-15
IT1248743B (it) 1995-01-26
NO911852L (no) 1991-11-15

Similar Documents

Publication Publication Date Title
AR244238A1 (es) Proceso para la preparacion de n-alquil polihidroxi aminas.
DE68912657D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan.
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
DE69006951D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan.
BG95241A (bg) Метод за получаване на 2,9-дизаместени-4н-пиридо/1.2-а/ пиримидин-4-они
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
FR2661919B1 (fr) Methode de preparation de derives de furo (3,4-c) pyridine sous forme non-racemique.
MA21984A1 (fr) Procede pour la preparation de derives de quilinone .
FI896075A7 (fi) Menetelmä 4,5,6,7-tetrahydrobentsimidatsolijohdosten valmistamiseksi
FI882165A7 (fi) Menetelmä 4-amino-androsteenidioni-johdannaisten valmistamiseksi.
DE59103466D1 (de) Verfahren zur Herstellung von Alkylydroxyanilino-triazinthioderivaten.
ZA898775B (en) Cyclopropyl-substituted azolylmethylcarbinols,processes for their preparation and their use as medicaments
DE3887212D1 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
EP0421216A3 (en) Process for the preparation of 2,4, resp. 2,6 dihalo-aniline
FI874413A7 (fi) Menetelmä aralkyyli-4H-1,2,4 -triatsolijohdannaisten valmistamiseksi.
MA21499A1 (fr) Procede de preparation de nouveaux derives de la i-arylsylfonyl 2-pyrrolidinone.
DE69106897D1 (de) Verfahren zur Herstellung von Haloketosäureabkömmlingen.
CS390991A3 (en) Thiadiazinone derivatives, process of their preparation andpharmaceuticals based thereon
DE69009651D1 (de) Verfahren zur Herstellung von 3,4-Dihydrocumarinderivaten.
ZA927464B (en) Process for the preparation of nucleoside derivatives.
IT8522035A0 (it) Procedimento di preparazionedi derivati di 6-sostituita-furo-(3,4-c)-piridina.
BE881764A (fr) NOUVEAUX DERIVES DE LA PYRIDO (3,4-e) -ASTRIAZINE ET PROCEDE DE PREPARATION DE CES DERIVES
NO174150C (no) Fremgangsmåte for fremstilling av furo-(3,4-c)pyridin-derivater i ikke-racemisk form
ZA929419B (en) Process for the preparation of trifluorobenzene derivatives.
FR2647450B1 (fr) Procede de preparation des derives de 2(prime), 3(prime)-dideshydro-2(prime),3(prime)-didesoxynucleoside

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name